Mylan (MYL) volatility flat into announces FDA approval of ANDAs for Glatiramer Acetate Injection
Go back to Mylan (MYL) volatility flat into announces FDA approval of ANDAs for Glatiramer Acetate Injection| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
